Rakovina Therapeutics
C$0.1
8
-C$0.01-5% Monday 13:30
Statistics
Day High
0.1
Day Low
0.1
52W High
0.85
52W Low
0.09
Volume
5,312
Avg. Volume
25,004
Mkt Cap
20.09M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
24AprExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-8.14MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow RKV.V. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap298.84B
Bristol-Myers Squibb
BMY
Mkt Cap121.69B
Pfizer
PFE
Mkt Cap161.09B
Lilly(Eli) &
LLY
Mkt Cap837.36B
Astrazeneca
AZN
Mkt Cap315.47B
Gilead Sciences
GILD
Mkt Cap173.41B
AMGEN
AMGN
Mkt Cap187.56B
Regeneron Pharmaceuticals
REGN
Mkt Cap80.54B
Novartis
NVS
Mkt Cap297.32B
Johnson & Johnson
JNJ
Mkt Cap585.7B
About
Rakovina Therapeutics Inc., a biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets. The company's preclinical product pipeline include kt-2000AI, an poly(ADP)-ribose polymerase (PARP) brain penetrant cancer therapy; kt-3000, a bi-functional small-molecule drug candidate; kt-3283 series for the treatment of PARP resistant adult and childhood cancers; and kt-4000, a DNA-damaging DDR inhibitors. It has a research collaboration with Variational AI Inc. to identify and develop novel small-molecule therapies against DNA-damage response (DDR) targets for the treatment of cancer. Additionally, it signed a letter of intent with NanoPalm Ltd. to form a joint venture to co-develop novel small-molecule oncology therapeutics. The company was formerly known as Vincero Capital Corp. Rakovina Therapeutics Inc. is headquartered in Vancouver, Canada.
Show more...
CEO
Dr. Mads Daugaard Ph.D.
Country
CA
ISIN
CA75103L3092
Listings
0 Comments
Share your thoughts
FAQ
What is Rakovina Therapeutics stock price today?▼
The current price of RKV.V is C$0.1 CAD — it has decreased by -5% in the past 24 hours. Watch Rakovina Therapeutics stock price performance more closely on the chart.
What is Rakovina Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Rakovina Therapeutics stocks are traded under the ticker RKV.V.
Is Rakovina Therapeutics stock price growing?▼
RKV.V stock has risen by +5.56% compared to the previous week, the month change is a -32.14% fall, over the last year Rakovina Therapeutics has showed a +26.67% increase.
What is Rakovina Therapeutics market cap?▼
Today Rakovina Therapeutics has the market capitalization of 20.09M
When is the next Rakovina Therapeutics earnings date?▼
Rakovina Therapeutics is going to release the next earnings report on April 24, 2026.
What were Rakovina Therapeutics earnings last quarter?▼
RKV.V earnings for the last quarter are -0.08 CAD per share, whereas the estimation was N/A CAD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A CAD per share.
What is Rakovina Therapeutics revenue for the last year?▼
Rakovina Therapeutics revenue for the last year amounts to 0 CAD.
What is Rakovina Therapeutics net income for the last year?▼
RKV.V net income for the last year is -8.14M CAD.
In which sector is Rakovina Therapeutics located?▼
Rakovina Therapeutics operates in the Health Care sector.
When did Rakovina Therapeutics complete a stock split?▼
The last stock split for Rakovina Therapeutics was on June 24, 2025 with a ratio of 1:10.
Where is Rakovina Therapeutics headquartered?▼
Rakovina Therapeutics is headquartered in Vancouver, CA.